Panic disorder

References

Angst J. Depression and anxiety: implications for nosology, course and treatment. J Clin Psychiatry 1997; 58 (Suppl 8): 3-5.

Bell CJ, Nutt DJ. Serotonin and panic. Br J Psychiatry 1998; 172: 465-471.

Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995; 10: 45-49.

den Boer JA, Westenberg HGM. Serotonin function in panic disorder, a double-blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 1990; 102: 85-94.

DeVane CL. The place of selective serotonin reuptake inhibitors in the treatment of panic disorder. Pharmacotherapy 1997; 17(2): 282-292.

EmmelkampPMG, Wessels H. Flooding in imagination vs flooding in vivo: a comparison with agoraphobia. Behaviour Res Ther 1975; 13: 7-15.

Estivill 2001- Human Genome project

Gorman JM, Keck PE Jr, Herschfeld RMA, Keller MB. The use of newer antidepressants for panic disorder. J Clin Psychiatry 1997; 58 (Suppl 14): 54-58.

Gorman JM, Liebowitz MR, Fyer AJ, et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987; 7: 329-332.

Gorman JM, Wolkow R. Sertraline as a treatment for panic disorder. Neuropsychopharmacology 1994; 10: 35-197.

Hoehn-Saric R, McLeod DR, Hipsley PA. Effect of fluvoxamineon panic disorder. J Clin Psychopharmacol 1993; 50: 44-50.

Johnson MR, Lyiard RB, Ballenger JC. Panic disorder: pathophysiology and drug treatment. Drugs 1995; 49: 328-344.

Joubert AF, Stein DJ. SSRIs in the treatment of anxiety disorders. Rev Contemp Psychopharm 1999; 10 (2): 79-131.

Katerndahl DA, Realini JP. Lifetime prevalence of panic states. Am J Psychiatry 1993; 150: 246-249.

Lepola U. Alcohol and depression in panic disorder. Acta Psychiatr Scand Suppl 1994; 377: 33-35.

Lepola UM, Wade AG, Leinonen EV, et al. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry. 1998; 59(10): 528-534.

Muzina DJ, Malone DA. Panic disorder in primary care: a cause of unexplained symptoms. Clev Clin J Med 1997; 64(8): 437-443.

Noyes R, Garvey MJ, Cook BL. Follow-up study of aptients with panic disorder or agoraphobia with panic attacks treated with tricyclic antidepressants. J Affect Disord 1989; 16: 249-257.

Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167: 374-379.

Schneier FR, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990; 10: 119-121.

Sheehan DV, Raj BA. Panic disorder in primary care: a US perspective. Primary Care Psychiatry 1998; 4: 10-28.

Starcevic V, Uhlenhuth EH, Kellner R, Pathak D. Comorbidity in panic disorder. II: Chronology of appearance and pathogenic comorbidity. Psychiatry Res 1993; 46: 285-293.

Tiller JWG, Bouwer C, Behnke K. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder. Int Clin Psychopharmacol 1997; 12 (Suppl 6): 27-30

Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T. The effect of citalopram in panic disorder. Br J Psychiatry 1997; 170: 549-553.

Yonkers KA, Zlotnick C, Allsworth AB, Warshaw M, Shea T, Keller MB. Is the course of panic disorder the same in women and men? Am J Psychaitry 1998; 155: 596-602.